ASCO 2022 Conference Coverage
Playback speed
10 seconds
ASCO 2022 Survival Outcomes in Metastatic HR+, HER2- IDC Compared to ILC and Mixed Ductal/Lobular Treated With ET in Combination With CDK4/6is/mTORi/PI3Ki
By
ASCO 2022 Conference Coverage
FEATURING
Jason Mouabbi
By
ASCO 2022 Conference Coverage
FEATURING
Jason Mouabbi
796 views
June 9, 2022
Login to view comments.
Click here to Login
Breast